Previous close | 14.05 |
Open | N/A |
Bid | 0.00 |
Ask | 4.80 |
Strike | 395.00 |
Expiry date | 2024-05-31 |
Day's range | 14.05 - 14.05 |
Contract range | N/A |
Volume | |
Open interest | 4 |
Financial Performance Aligns with Analyst Projections Despite Revenue Dip
CRISPR Therapeutics (CRSP) reports mixed earnings results for first-quarter 2024. Management claims that the commercial launch for the first ever CRISPR-based gene therapy is progressing well.
As you might know, Vertex Pharmaceuticals Incorporated ( NASDAQ:VRTX ) just kicked off its latest quarterly results...